Download Sample
Add to CartVeterinary Cannabidiol (CBD) Market
By Product;
Food-Grade, Therapeutic-Grade and Personal CareBy Distribution Channel;
E-Commerce, Retail Pharmacies and Vet Care ClinicsBy Source;
Marijuana-Derived and Hemp-DerivedBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Veterinary Cannabidiol (CBD) Market Overview
Veterinary Cannabidiol (CBD) Market (USD Million)
Veterinary Cannabidiol (CBD) Market was valued at USD 205.25 million in the year 2024. The size of this market is expected to increase to USD 3,539.79 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 50.2%.
Veterinary Cannabidiol (CBD) Market
*Market size in USD million
CAGR 50.2 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 50.2 % |
| Market Size (2024) | USD 205.25 Million |
| Market Size (2031) | USD 3,539.79 Million |
| Market Concentration | Low |
| Report Pages | 336 |
Major Players
- Honest Paws
- HolistaPet
- HempMy Pet
- Canna-Pet
- Joy Organics
- Fomo Bones
- Pet Releaf
- Green Roads of Florida
- Wet Noses
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Veterinary Cannabidiol (CBD) Market
Fragmented - Highly competitive market without dominant players
The Veterinary Cannabidiol (CBD) Market is witnessing strong momentum as pet owners increasingly adopt natural solutions for animal health. Over 55% of pet owners now express interest in CBD-based treatments, largely due to their effectiveness in addressing pain, inflammation, anxiety, and seizures in companion animals. This trend reflects a growing trust in CBD as a reliable and holistic therapeutic option.
Growing Preference for Natural Remedies
The rising inclination toward plant-based therapies has positioned CBD as a top choice in veterinary care. Research highlights that nearly 50% of pet care consumers now prefer natural alternatives over conventional drugs. With its proven ability to support preventive health and manage chronic issues, veterinary CBD is becoming a cornerstone of modern animal wellness practices.
Rising Expenditure on Pet Healthcare
Increasing pet healthcare spending is fueling the adoption of CBD-infused products across the industry. Surveys reveal that around 60% of pet owners are willing to invest in advanced care solutions that enhance the overall well-being of their pets. This willingness to spend more is encouraging the development of premium CBD oils, treats, and supplements, designed for ease of use and maximum therapeutic impact.
Innovations Driving Market Expansion
Continuous research and innovation are shaping the growth of this market, with nearly 40% of new veterinary supplements integrating CBD as a key ingredient. Enhanced formulations, precise dosing mechanisms, and extended-release products are boosting both safety and efficacy. These innovations not only improve treatment outcomes but also broaden the spectrum of veterinary CBD applications.
Future Growth Opportunities
The veterinary CBD market holds strong growth potential, backed by rising consumer awareness, greater acceptance by veterinarians, and expanding product pipelines. Reports indicate that more than 45% of veterinarians now recommend CBD as part of integrated pet care strategies. This expanding endorsement highlights CBD’s path toward becoming a mainstream solution in veterinary medicine.
Veterinary CBD Market Recent Developments
-
November 2022: Sky Wellness, a company providing people and animals with CBD, relaunched its CBD wellness collection for dogs under its D Oh Gee brand. The collection includes three broad-spectrum, THC-free CBD products formulated to support joint health and mobility.
-
August 2022: Pet Releaf launched a line of CBD grooming products for dogs, which include skin and coat relief shampoos.
-
March 2022: Healthy TOKYO launched its first CBD pet line of products comprising CBD-infused treats and supplements for cats and dogs in Japan.
Veterinary CBD Segment Analysis
In this report, the Veterinary CBD Market has been segmented by Source, Product, Distrubution Channel and Geography.
Veterinary CBD Market, Segmentation by Source
The Veterinary CBD Market has been segmented by Source into Hemp-Derived and Marijuana-Derived.
Hemp-Derived
The hemp-derived segment leads the veterinary CBD market with close to 82% share, reflecting its strong acceptance across global markets. Its low THC concentration makes it safe for companion animals, driving its popularity in formulations for pain relief, anxiety reduction, and overall pet wellness. With growing consumer trust and regulatory approvals, hemp-derived CBD continues to dominate product development.
Marijuana-Derived
The marijuana-derived segment represents nearly 18% of the market, constrained by regulatory restrictions in many countries. Despite this, it is slowly expanding in regions with progressive cannabis legislation, particularly for specialized veterinary treatments. Its use in advanced therapeutic solutions highlights its potential for future growth once broader approvals are secured.
Veterinary CBD Market, Segmentation by Product
The Veterinary CBD Market has been segmented by Product into Food-Grade - [Pet Treats, Soft Chews and Others] and Therapeutic-Grade - [Pet Supplements, and Pet CBD Oils, Personal Care]
Food-Grade – Pet Treats
The pet treats segment leads the food-grade veterinary CBD category with approximately 28% share, reflecting strong consumer preference for convenient CBD-infused snacks. These products are widely used to promote calmness, joint flexibility, and overall pet wellness, making them a popular choice among pet owners.
Food-Grade – Soft Chews
The soft chews segment captures nearly 22% of the market, driven by their palatable flavors and ease of administration. Especially beneficial for pets with anxiety and mobility issues, soft chews improve compliance while delivering effective CBD benefits.
Food-Grade – Others
The others segment under food-grade accounts for close to 10% of the market, covering CBD powders, capsules, and fortified foods. These products serve niche demands, including pets with special dietary requirements and targeted health needs.
Therapeutic-Grade – Pet Supplements
The pet supplements segment dominates the therapeutic-grade category with about 20% share, supported by widespread adoption of CBD-based supplements. These products play a significant role in managing pain, inflammation, and overall immune health in pets.
Therapeutic-Grade – Pet CBD Oils
The pet CBD oils segment represents nearly 15% of the market, favored for their precise dosing and versatility. Oils are widely prescribed for chronic conditions such as arthritis, seizures, and stress, positioning them as a vital therapeutic option.
Therapeutic-Grade – Personal Care
The personal care segment contributes around 5% of the market, highlighting the growing use of CBD in shampoos, balms, and creams. These products are increasingly recognized for treating skin irritations, allergies, and localized discomfort in animals.
Veterinary CBD Market, Segmentation by Distrubution Channel
The Veterinary CBD Market has been segmented by Distrubution Channel into E-Commerce Websites, Retail Pharmacies, Veterinary Clinics and Others.
E-Commerce Websites
The e-commerce websites segment leads the veterinary CBD market with nearly 40% share, highlighting the dominance of digital platforms. Pet owners increasingly favor online purchasing due to its convenience, wider product range, and cost benefits, making this channel the fastest-growing.
Retail Pharmacies
The retail pharmacies segment represents close to 25% of the distribution market, supported by strong consumer reliance on pharmacy chains. With access to verified and certified veterinary CBD products, pharmacies continue to build trust among buyers, strengthening their role in the market.
Veterinary Clinics
The veterinary clinics segment captures nearly 20% share, driven by veterinarians’ authority in prescribing and recommending CBD products. Their professional guidance enhances product credibility and promotes the therapeutic use of CBD in pets.
Others
The others segment accounts for about 15% of the market, including specialty outlets and local stores. Although smaller in scale, this channel fulfills niche needs and ensures greater accessibility of veterinary CBD products across diverse regions.
Veterinary CBD Market, Segmentation by Geography
In this report, the Veterinary CBD Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Regions and Countries Analyzed in this Report
Veterinary CBD Market Share (%), by Geographical Region
North America
The North America segment dominates the veterinary CBD market with nearly 45% share, supported by a well-structured regulatory framework and widespread consumer awareness. Established brands continue to strengthen their presence, making the region the largest contributor.
Europe
The Europe segment represents close to 25% of the market, with growing legalization and increasing preference for natural therapies for pets. Expanding investments in animal health and wellness are accelerating the demand for veterinary CBD.
Asia Pacific
The Asia Pacific segment contributes nearly 15%, driven by increasing pet ownership and rising disposable incomes. Markets such as Japan, China, and Australia are witnessing growing acceptance of CBD-based veterinary treatments.
Middle East & Africa
The Middle East & Africa segment accounts for about 8%, where gradual adoption of veterinary CBD is supported by expanding retail and e-commerce channels. Improved distribution is enhancing availability in emerging economies.
Latin America
The Latin America segment holds around 7%, with Brazil and Mexico leading growth. Despite being in early stages of adoption, the region is showing rising interest in alternative and natural therapies for pets.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Veterinary CBD Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing Pet Wellness Awareness
- Growing Acceptance of CBD Products
-
Rising Veterinary Recommendations - The global veterinary CBD market is witnessing a significant surge, driven by increasing recommendations from veterinarians. As more research emerges highlighting the potential benefits of CBD in managing various health conditions in animals, veterinarians are increasingly integrating CBD into their treatment protocols. This shift is particularly notable in managing issues like pain, anxiety, inflammation, and seizures in pets. With pet owners showing a growing interest in natural and holistic approaches to pet care, CBD products are gaining traction as viable alternatives to traditional pharmaceuticals.
The legalization of CBD in several regions has further propelled market growth, fostering innovation and the development of a diverse range of CBD-infused products specifically tailored for pets. Veterinary clinics and pet stores are increasingly stocking CBD products, catering to the rising demand from pet owners seeking safe and effective solutions for their furry companions' health and well-being. As regulatory frameworks continue to evolve and consumer awareness regarding CBD expands, the veterinary CBD market is poised for continued expansion in the coming years.
Restraints:
- Regulatory Uncertainties
- Limited Clinical Evidence
-
Concerns Over Product Quality and Safety - The global veterinary CBD market is witnessing significant growth, driven by increasing consumer demand for alternative therapies for pets' ailments. However, this burgeoning market is also accompanied by concerns over the quality and safety of CBD products intended for animal use.
Regulatory oversight varies widely across regions, leading to inconsistencies in product quality standards and labeling practices. This lack of uniformity raises apprehensions among pet owners regarding the reliability and effectiveness of CBD products for their beloved companions. Moreover, the absence of comprehensive testing protocols and standardized dosing guidelines further compounds these concerns, leaving both veterinarians and consumers uncertain about the optimal use of CBD in veterinary medicine.
Opportunities:
- Expanding Product Portfolio
- Emerging Markets Adoption
-
Collaborations with Veterinary Professionals - In the burgeoning global market for veterinary CBD products, collaborations with veterinary professionals have emerged as pivotal initiatives. These partnerships facilitate a deeper understanding of the potential benefits and risks associated with CBD use in animals. Through collaborative efforts, veterinarians can contribute their clinical expertise, offering insights into dosage, efficacy, and potential interactions with other medications. This collaboration ensures that CBD products are developed and administered in a manner that prioritizes animal welfare and aligns with established veterinary practices.
Collaborations between CBD manufacturers and veterinary professionals play a crucial role in advancing research in this field. By combining resources and expertise, these partnerships can support clinical trials and studies aimed at elucidating the therapeutic effects of CBD on various animal species. Through rigorous scientific inquiry, veterinarians and researchers can generate evidence-based guidelines for the use of CBD in veterinary medicine, fostering confidence among pet owners and regulatory bodies. Ultimately, these collaborations drive innovation and contribute to the responsible and ethical integration of CBD products into veterinary care.
Veterinary Cannabidiol (CBD) Market Competitive Landscape Analysis
Veterinary Cannabidiol (CBD) Market is witnessing increased competition as manufacturers refine their strategies to meet rising demand across companion and livestock care. Intense collaboration and emerging partnerships among producers, distributors, and research groups fuel sector growth. Companies focus on differentiated product profiles, premium formulations, and veterinary endorsement to secure sustainable market positioning.
Market Structure and Concentration
The market shows a mix of specialized players and emerging entrants, creating a moderately fragmented structure. Top participants control significant percentages (%) through targeted merger activities and exclusive distribution agreements. Smaller firms leverage niche innovation and agility to compete effectively, while well-established brands expand their influence through diversified product portfolios and long-term supply partnerships.
Brand and Channel Strategies
Leading companies strengthen brand presence by optimizing retail and digital channels, enhancing customer trust, and fostering veterinary recommendations. Strong strategies in e-commerce and specialized pet health stores help boost accessibility and visibility. Promotional collaborations with clinics and training programs for professionals create deeper end-user confidence, further propelling competitive growth.
Innovation Drivers and Technological Advancements
Continuous product innovation shapes market competitiveness as companies introduce improved CBD delivery methods and precise dosage technologies. Advanced extraction techniques and enhanced technological advancements ensure better safety and efficacy profiles. Partnerships between research institutions and producers accelerate product approvals and increase the pace of differentiation, supporting ongoing market expansion.
Regional Momentum and Expansion
Regional leaders drive competitive influence by adapting to varying veterinary regulations and pet care trends. Aggressive expansion into fast-growing areas through joint ventures and strategic collaboration increases market penetration. Tailored formulations and specialized distribution networks strengthen brand positioning, while localized strategies build resilience against regulatory and competitive pressures.
Future Outlook
The competitive landscape is set for accelerated growth as more players invest in advanced research and innovative marketing models. Continued partnerships between technology providers and veterinary networks will refine supply chains and product credibility. Market leaders aim to expand their reach by embracing evolving regulations and strengthening long-term strategies that enhance competitiveness and trust.
Key players in Veterinary CBD Market include:
- Honest Paws
- HolistaPet
- HempMy Pet
- Canna-Pet
- Joy Organics
- Fomo Bones
- Pet Releaf
- Green Roads of Florida
- Wet Noses
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Source
- Market Snapshot, By Region
- Veterinary Cannabidiol (CBD) Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Pet Wellness Awareness
- Growing Acceptance of CBD Products
- Rising Veterinary Recommendations
- Restraints
- Regulatory Uncertainties
- Limited Clinical Evidence
- Concerns Over Product Quality and Safety
- Opportunities
- Expanding Product Portfolio
- Emerging Markets Adoption
- Collaborations with Veterinary Professionals
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Veterinary Cannabidiol (CBD) Market, By Product, 2021 - 2031 (USD Million)
- Food-Grade
- Therapeutic-Grade
- Personal Care
- Veterinary Cannabidiol (CBD) Market, By Distribution Channel, 2021 - 2031 (USD Million)
- E-Commerce
- Retail Pharmacies
- Vet Care Clinics
- Veterinary Cannabidiol (CBD) Market, By Source, 2021 - 2031 (USD Million)
- Marijuana-Derived
- Hemp-Derived
- Veterinary Cannabidiol (CBD) Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Veterinary Cannabidiol (CBD) Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Honest Paws
- HolistaPet
- HempMy Pet
- Canna-Pet
- Joy Organics
- Fomo Bones
- Pet Releaf
- Green Roads of Florida
- Wet Noses
- Company Profiles
- Analyst Views
- Future Outlook of the Market